Met estimates pretty much. Wonder how much of a hit we take for the trial halting, so far its a muted reaction premarket. All this really makes you wonder about the heavy volume on the upside. One more buying opp. before we head to 50 and that party on the Island))
The issues causing the sell off are pretty much old news. HALO had similar issues last year when the stock went under $4. It is the HALO formulation that VPHM is using. Other companies, Roche and others, use an improved version of the HALO product that doesn't cause anti-bodies. Wonder why VPHM took so long to pull the plug on the trials with this known side effect. At least they have a back up plan.